Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, RIGHT Institute/MedINNPharmaBesançon, France
0940: A Novel Therapeutic Opportunity in Systemic Sclerosis: The Fibrolytic Activities of a Specialized Macrophage Secretome
Monday, November 13, 20239:00 AM – 11:00 AM PT
Disclosure information not submitted.